SEC Form 4 · accession 0001104659-18-044688
Ophthotech Corp. · OPHT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David E Redlick
Director
Period of report
May 23, 2018
Accepted (ET)
Jul 11, 2018 · 4:45 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410939
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.775 | May 23, 2018 | A | 16,000 | A | — | May 22, 2028 | Common Stock | 16,000 | 16,000 | D |
Explanation of responses
- F1Subject to Reporting Person providing continued services to the Issuer and other terms and conditions under the Registrant's 2013 Stock Incentive Plan, the option will vest and become exercisable in 12 consecutive, equal installments on each consecutive monthly anniversary of the date of grant, until fully vested and exercisable on the first anniversary of the date of grant. Any unvested shares subject to the option will be accelerated in full one business day prior to the Issuer's 2019 annual meeting of stockholders.